Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$13,491,678
+$1,830,517 QoQ
Shares Held
53,615
-0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#779
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BBR PARTNERS, LLC holds $25,619,055 across 7 Drug Manufacturers - General names. ABBV ranks #1 (52.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
53,615 | $13,491,678 | |
| 2 | JNJ |
Johnson & Johnson
|
27,913 | $7,089,064 | |
| 3 | AMGN |
Amgen Inc
|
5,580 | $2,020,629 | |
| 4 | LLY |
ELI LILLY & Co
|
1,523 | $1,826,732 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,889 | $512,184 | |
| 6 | PFE |
Pfizer Inc
|
18,751 | $451,524 | |
| 7 | NVS |
Novartis AG
|
1,450 | $227,244 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,491,678 | 53,615 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $11,661,161 | 53,617 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,394,668 | 54,246 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $12,577,947 | 54,323 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $10,068,771 | 54,244 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,261,948 | 58,524 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,401,314 | 58,533 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $12,138,108 | 61,465 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,414,218 | 54,887 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $11,481,222 | 63,049 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,663,597 | 55,905 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,243,316 | 55,302 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,993,564 | 51,908 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $8,305,886 | 52,117 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,436,365 | 52,202 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,998,783 | 52,148 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,368,049 | 54,636 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,938,096 | 55,136 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,238,761 | 38,691 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,155,583 | 38,524 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,670,504 | 41,464 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,524,353 | 41,807 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,476,834 | 41,781 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,652,240 | 41,697 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,773,057 | 38,430 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,148,246 | 41,321 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||